查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無菌注射劑契約製造市場規模、佔有率、趨勢分析報告：按分子類型、給藥途徑、治療用途、最終用途、地區和細分市場預測，2023-2030年
市場調查報告書
商品編碼
1321481

無菌注射劑契約製造市場規模、佔有率、趨勢分析報告：按分子類型、給藥途徑、治療用途、最終用途、地區和細分市場預測，2023-2030年

Sterile Injectable Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type, By Route Of Administration, By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 195 Pages | 商品交期: 2-10個工作天內

價格

無菌注射劑契約製造市場的成長和趨勢

根據 Grand View Research, Inc. 的最新報告，預計到2030年，全球無菌注射劑契約製造市場規模將達到 319.2 億美元，2023年至2030年年複合成長率為 12.1%。

無菌注射劑契約製造行業成長的推動因素包括注射劑管道和批准的增加、對生物製劑和生物學名藥的需求增加、開發新療法的研發活動投資增加以及對細胞和基因治療的需求要素。無菌注射劑的契約製造市場較為分散，多家公司擁有相似的技術和加工能力。

具有管理高效價藥物等獨特能力的契約製造組織（CMO）預計將主導該行業。歐洲和美國有各種無菌注射劑 CMO，擁有歐盟 GMP 和美國FDA 批准的設施。此外，印度和中國等新興經濟體預計在預測期內將出現良好的成長。這是由於這些國家對注射藥品採購服務的需求不斷增加。印度有20 多家獲得歐盟 GMP/美國FDA 注射劑認證的 CMO。由於製藥巨頭對新興市場具有成本效益的外包服務的需求不斷增加，印度的無菌注射劑契約製造行業迅速擴張。儘管印度大多數注射劑 CMO 一直在迎合當地需求，但近年來這種轉變已變得明顯。

COVID-19 大流行對無菌注射劑契約製造行業產生了積極影響。這是由於2020年至2021年對 COVID-19 疫苗的需求大幅增加。市場上的主要參與者也採用合併、收購和聯盟等無機戰略舉措來增強其市場地位。此外，近年來，多家公司致力於進入注射劑契約製造行業。例如，全球私人投資公司 Bridgewest Group 宣布推出致力於無菌注射劑的新受託製造廠商(CDMO) 設施。

無菌注射劑契約製造市場報告亮點

  • 2022年，大分子細分市場將佔據最大佔有率，達到61.3%。該領域的成長是由對大分子治療的需求不斷成長推動的，包括細胞和基因治療以及 RNA 治療，它們佔大分子的大部分。
  • 按治療用途來看，癌症領域佔比最大，2022年將達到28.5%。該細分市場佔有率的增加主要是由於對基於抗癌藥物的注射療法的需求增加。
  • 皮下 (SC) 領域預計在預測期內年複合成長率最快，達到 12.6%。這是因為皮下注射劑由於與注射疫苗、生長激素和胰島素相關的益處而在全球範圍內需求量很大。
  • 隨著越來越多的生物製藥公司投資開發新型無菌注射劑，預計生物製藥公司在預測期內的年複合成長率將達到 12.4%。
  • 亞太地區預計在預測期內年複合成長率高達 13.1%。這種高成長主要是由於越來越多的西方製藥公司將其製造業務外包給印度和中國等新興經濟體。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 無菌注射劑契約製造市場變量、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/輔助市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 無菌注射劑契約製造市場分析工具
    • 行業分析-波特
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 無菌注射劑契約製造市場：分子類型估計和趨勢分析

  • 無菌注射劑契約製造市場，按分子類型：細分儀表板
  • 按分子類型分類的無菌注射劑契約製造市場：變動分析
    • 低分子
    • 高分子

第5章 無菌注射劑契約製造市場：治療用途的估計和趨勢分析

  • 無菌注射劑契約製造市場，按治療用途：細分儀表板
  • 無菌注射劑契約製造市場，按治療用途分類：變動分析
    • 癌症
    • 糖尿病
    • 心血管疾病
    • 中樞神經系統疾病
    • 感染疾病
    • 肌肉骨骼系統
    • 抗病毒藥
    • 其他

第6章 無菌注射劑契約製造市場：給藥途徑預估及趨勢分析

  • 無菌注射劑契約製造市場，按管理途徑：細分儀表板
  • 無菌注射劑契約製造市場，按管理途徑：變動分析
    • 皮下注射（SC）
    • 靜脈注射(IV)
    • 肌內注射 (IM)
    • 其他

第7章 無菌注射劑契約製造市場：最終用途估計和趨勢分析

  • 無菌注射劑契約製造市場，按最終用途：細分儀表板
  • 按最終用途的無菌注射劑契約製造市場：變動分析
    • 製藥公司
    • 生物製藥公司
    • 其他

第8章 無菌注射劑契約製造市場：區域估計和趨勢分析

  • 2022年和2030年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美
    • 2018-2030年市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 市場參與企業分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 2022年公司市場佔有率分析
  • 公司簡介
    • Baxter
    • Catalent, Inc
    • Vetter Pharma
    • Recipharm AB
    • Aenova Group
    • Fresenius Kabi
    • Unither Pharmaceuticals
    • Famar
    • Cipla Inc.
    • NextPharma Technologies
Product Code: GVR-4-68040-097-0

Sterile Injectable Contract Manufacturing Market Growth & Trends

The global sterile injectable contract manufacturing market size is estimated to reach USD 31.92 billion by 2030, growing at a CAGR of 12.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pipeline and approvals of injectables, growing demand for biologics and biosimilars, rise in investment in research & development activities for the development of novel therapeutics, and increasing demand for cell & gene therapies are the key factors driving the growth of sterile injectable contract manufacturing industry. The market for sterile injectable contract manufacturing is fragmented, with several players having similar technological and processing capabilities.

Contract Manufacturing Organizations (CMOs) with unique capabilities, such as the management of high-potency drugs, are anticipated to dominate the industry. In Europe and the U.S., there are various sterile injectable CMOs with EU GMP and U.S. FDA-approved facilities. Moreover, developing economies such as India and China are anticipated to witness lucrative growth across the forecast period. This is attributable to the increasing demand for injectable sourcing services across these countries. India has over 20 CMOs with EU GMP/U.S. FDA injectable certifications. The Indian sterile injectable contract manufacturing industry is rapidly expanding due to rising demand for outsourcing services from the pharmaceutical giants to emerging markets for cost-effectiveness. Most Indian injectable CMOs have been catering to local demand, but the transition has been evident over the past few years.

The COVID-19 pandemic positively impacted the sterile injectable contract manufacturing industry. This was because of the huge surge in demand for COVID-19 vaccines from 2020 to 2021, as these vaccines are a major part of the injectables industry. In addition, major players in the market are adopting inorganic strategic initiatives such as mergers, acquisitions, and partnerships to enhance their market positions. Furthermore, for the past few years, several companies have focused on penetrating the injectable contract manufacturing industry. For instance, Bridgewest Group, a global private investment firm, announced the launch of a new contract development and manufacturing organization (CDMO) facility focused on sterile injectable drug products.

Sterile Injectable Contract Manufacturing Market Report Highlights

  • The large molecule segment accounted for the largest share of 61.3% in 2022. The segment's growth is driven by increasing demand for large molecule-based therapeutics such as cell & gene therapy, RNA therapy, etc., which constitute a vast portion of large molecules
  • Based on therapeutic application, the cancer segment accounted for the largest share of 28.5% in 2022. The growth in the share of this segment is majorly due to the increasing demand for anti-cancer-based injectable therapeutics
  • The Subcutaneous (SC) segment is anticipated to register the fastest CAGR of 12.6% during the forecast period. This is because of the high demand for SC injectables globally, owing to their associated benefits while administering vaccines, growth hormones, and insulin
  • Biopharmaceutical companies are anticipated to witness the highest CAGR of 12.4% over the forecast period due to the increasing number of biopharmaceutical companies investing in developing novel sterile injectables
  • Asia Pacific is anticipated to witness the highest CAGR of 13.1% during the forecast period. This high growth is primarily due to the increasing number of Western pharmaceutical companies outsourcing their manufacturing activities to developing economies such as India and China

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Molecule Type
    • 1.1.3. Therapeutic Application
    • 1.1.4. Route of Administration
    • 1.1.5. End-use
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sterile Injectable Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Pipeline and Approvals of Injectables
      • 3.2.1.2. Growing Demand for Biologics and Biosimilars Significantly Supported Market Growth
      • 3.2.1.3. Rise in Investment Across Research & Development Activities for the Development of Novel Therapeutics.
      • 3.2.1.4. Increasing Demand for Cell & Gene Therapies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Low Barriers to Market Penetration Have Resulted in Pricing Pressure
      • 3.2.2.2. Challenges Related to Quality Control
  • 3.3. Sterile Injectable Contract Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Sterile Injectable Contract Manufacturing Market: Molecule Type Estimates & Trend Analysis

  • 4.1. Sterile Injectable Contract Manufacturing Market, By Molecule Type: Segment Dashboard
  • 4.2. Sterile Injectable Contract Manufacturing Market, By Molecule Type: Movement Analysis
  • 4.3. Sterile Injectable Contract Manufacturing Market Estimates & Forecasts, By Molecule Type, 2018 - 2030
    • 4.3.1. Small Molecule
      • 4.3.1.1. Small Molecule Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 4.3.2. Large Molecule
      • 4.3.2.1. Large Molecule Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)

Chapter 5. Sterile Injectable Contract Manufacturing Market: Therapeutic Application Estimates & Trend Analysis

  • 5.1. Sterile Injectable Contract Manufacturing Market, By Therapeutic Application: Segment Dashboard
  • 5.2. Sterile Injectable Contract Manufacturing Market, By Therapeutic Application: Movement Analysis
  • 5.3. Sterile Injectable Contract Manufacturing Market Estimates & Forecasts, By Therapeutic Application, 2018 - 2030
    • 5.3.1. Cancer
      • 5.3.1.1. Cancer Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.2. Diabetes
      • 5.3.2.1. Diabetes Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.3. Cardiovascular Diseases
      • 5.3.3.1. Cardiovascular Diseases Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.4. Central Nervous System Diseases
      • 5.3.4.1. Central Nervous System Diseases Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.5. Infectious Disorders
      • 5.3.5.1. Infectious Disorders Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.6. Musculoskeletal
      • 5.3.6.1. Musculoskeletal Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.7. Anti-Viral
      • 5.3.7.1. Anti-Viral Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)
    • 5.3.8. Others
      • 5.3.8.1. Others Sterile Injectable Contract Manufacturing Market, 2018 to 2030 (USD Million)

Chapter 6. Sterile Injectable Contract Manufacturing Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Sterile Injectable Contract Manufacturing Market, By Route of Administration: Segment Dashboard
  • 6.2. Sterile Injectable Contract Manufacturing Market, By Route of Administration: Movement Analysis
  • 6.3. Sterile Injectable Contract Manufacturing Market Estimates & Forecasts, By Route of Administration, 2018 - 2030
    • 6.3.1. Subcutaneous (SC)
      • 6.3.1.1. Subcutaneous (SC) Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)
    • 6.3.2. Intravenous (IV)
      • 6.3.2.1. Intravenous (IV) Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)
    • 6.3.3. Intramuscular (IM)
      • 6.3.3.1. Intramuscular (IM) Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Others Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)

Chapter 7. Sterile Injectable Contract Manufacturing Market: End-use Estimates & Trend Analysis

  • 7.1. Sterile Injectable Contract Manufacturing Market, By End-use: Segment Dashboard
  • 7.2. Sterile Injectable Contract Manufacturing Market, By End-use: Movement Analysis
  • 7.3. Sterile Injectable Contract Manufacturing Market Estimates & Forecasts, By End-use, 2018 - 2030
    • 7.3.1. Pharmaceutical Companies
      • 7.3.1.1. Pharmaceutical Companies Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)
    • 7.3.2. Biopharmaceutical Companies
      • 7.3.2.1. Biopharmaceutical Companies Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)
    • 7.3.3. Others
      • 7.3.3.1. Others Sterile Injectable Contract Manufacturing Market 2018 to 2030 (USD Million)

Chapter 8. Sterile Injectable Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2022 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Competitive Scenario
      • 8.5.1.3. Regulatory Framework
      • 8.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 8.5.2. Germany
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory Framework
      • 8.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 8.6.2. India
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 8.6.4. South Korea
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory Framework
      • 8.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 8.7.2. Mexico
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key Country Dynamics
      • 8.8.1.2. Competitive Scenario
      • 8.8.1.3. Regulatory Framework
      • 8.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 8.8.3. UAE
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 8.8.4. Kuwait
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Innovators
    • 9.1.2. Market Leaders
    • 9.1.3. Emerging Players
    • 9.1.4. Company Market Share Analysis, 2022
  • 9.2. Company Profiles
    • 9.2.1. Baxter
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Service Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Catalent, Inc
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Service Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Vetter Pharma
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Service Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Recipharm AB
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Service Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Aenova Group
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Service Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Fresenius Kabi
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Service Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Unither Pharmaceuticals
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Service Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Famar
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Service Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. Cipla Inc.
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Service Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. NextPharma Technologies
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Service Benchmarking
      • 9.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Sterile Injectable Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 5 North America Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 6 North America Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 North America Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 13 Canada Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Sterile Injectable Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 17 Europe Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Europe Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 22 UK Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 23 UK Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 Germany Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Germany Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 France Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 30 France Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 31 France Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 France Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 34 Italy Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Italy Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Spain Sterile Injectable Contract Manufacturing market, by Therapeutic Application type, 2018 - 2030 (USD Million)
  • Table 38 Spain Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 39 Spain Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Spain Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Denmark Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Denmark Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 46 Sweden Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Sweden Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Norway Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 50 Norway Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Norway Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Sterile Injectable Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 China Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 59 China Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 60 China Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 China Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 Japan Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Japan Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 India Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 67 India Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 68 India Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 India Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Australia Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 71 Australia Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 72 Australia Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Australia Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 75 South Korea Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 South Korea Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 78 Thailand Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 80 Thailand Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 Thailand Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 82 Latin America Sterile Injectable Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 83 Latin America Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 84 Latin America Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 85 Latin America Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Latin America Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Brazil Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 88 Brazil Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 89 Brazil Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Brazil Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Mexico Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 92 Mexico Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Mexico Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 Argentina Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 96 Argentina Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 98 Argentina Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa Sterile Injectable Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 South Africa Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 105 South Africa Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 107 South Africa Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 112 UAE Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 113 UAE Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 115 UAE Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Sterile Injectable Contract Manufacturing market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Sterile Injectable Contract Manufacturing market, by Molecule Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Sterile Injectable Contract Manufacturing market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Sterile Injectable Contract Manufacturing market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Primary research pattern
  • Fig. 8 Primary interviews in North America
  • Fig. 9 Primary interviews in Europe
  • Fig. 10 Primary interviews in Asia Pacific
  • Fig. 11 Primary interviews in Latin America
  • Fig. 12 Primary interviews in MEA
  • Fig. 13 Market Snapshot
  • Fig. 14 Segment Snapshot
  • Fig. 15 Segment Snapshot
  • Fig. 16 Competitive Landscape Snapshot
  • Fig. 17 Sterile Injectable Contract Manufacturing market segmentation
  • Fig. 18 Parent market outlook (2022)
  • Fig. 19 Related/ancillary market outlook (2022)
  • Fig. 20 Market driver relevance analysis (Current & future impact)
  • Fig. 21 Current shared services and outsourcing usage levels
  • Fig. 22 Market restraint relevance analysis (Current & future impact)
  • Fig. 23 Porter's five forces analysis
  • Fig. 24 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 25 Sterile Injectable Contract Manufacturing Market Molecule Type outlook: Segment dashboard
  • Fig. 26 Sterile Injectable Contract Manufacturing: Molecule Type movement analysis
  • Fig. 27 Small Molecule market, 2018 - 2030 (USD Million)
  • Fig. 28 Large Molecule market, 2018 - 2030 (USD Million)
  • Fig. 29 Sterile Injectable Contract Manufacturing Market Therapeutic Application outlook: Segment dashboard
  • Fig. 30 Sterile Injectable Contract Manufacturing: Therapeutic Application type movement analysis
  • Fig. 31 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 32 Diabetes market, 2018 - 2030 (USD Million)
  • Fig. 33 Cardiovascular Diseases market, 2018 - 2030 (USD Million)
  • Fig. 34 Central Nervous System Diseases market, 2018 - 2030 (USD Million)
  • Fig. 35 Infectious Disorders market, 2018 - 2030 (USD Million)
  • Fig. 36 Musculoskeletal market, 2018 - 2030 (USD Million)
  • Fig. 37 Anti-Viral market, 2018 - 2030 (USD Million)
  • Fig. 38 Others market, 2018 - 2030 (USD Million)
  • Fig. 39 Sterile Injectable Contract Manufacturing market Route of Administration outlook: Segment dashboard
  • Fig. 40 Sterile Injectable Contract Manufacturing market: Route of Administration movement analysis
  • Fig. 41 Subcutaneous (SC) market, 2018 - 2030 (USD Million)
  • Fig. 42 Intravenous (IV) market, 2018 - 2030 (USD Million)
  • Fig. 43 Intramuscular (IM) market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Segment dashboard
  • Fig. 45 Regional outlook, 2022 & 2030
  • Fig. 46 North America market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market, 2018 - 2030 (USD Million)
  • Fig. 51 UK market, 2018 - 2030 (USD Million)
  • Fig. 52 France market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark market, 2018 - 2030(USD Million)
  • Fig. 56 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 59 China market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market, 2018 - 2030 (USD Million)
  • Fig. 61 India market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East & Africa market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market, 2018 - 2030 (USD Million)